EpiTherapeutics' Seed VC - III Round

EpiTherapeutics raised a round of funding on December 16, 2010. Investors include Merck Ventures.

EpiTherapeutics is developing novel innovative cancer drugs based on the world leading research in epigenetics conducted by Professor Kristian Helin and his group at Biotech Research & Innovation Cent…

Articles about EpiTherapeutics' Seed VC - III Round: